Chapter 72- Tuberculosis

Description

IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Compare the risk for active tuberculosis disease among patients based on their age, immune status, place of birth, and time since exposure to an active case.
2. Design, evaluate, and assess an appropriate therapeutic plan for an immunocompetent, immunocompromised, pregnant, and pediatric patient.
3. Assess the effectiveness of therapy in tuberculosis patients.
4. Cite the names of the tuberculosis drugs most likely to cause hepatotoxicity.
5. Select patients for whom therapeutic drug monitoring may be valuable.
6. Design, evaluate, and assess appropriate regimens for the treatment of latent tunerculosis infection (LTBI) in all patient populations.
7. Identify the necessary laboratory monitoring parameters for patients on antituberculosis medications.
8. Design a therapeutic plan for a patient with tuberculosis meningitis or tunerculosis osteomyelitis.

Courses Offered